![Nicole Mowad-Nassar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 163 931 $ in data 31/07/2026
Nicole Mowad-Nassar is currently an Independent Non-Executive Director at ResMed, Inc. since 2025 and Vice President-Marketing at Takeda Pharmaceuticals U.S.A., Inc. Formerly, Ms. Mowad-Nassar was Senior Vice President & President-Specialty at AbbVie, Inc. from 2023 to 2025.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 24/11/2025 | 777 ( 0% ) | 163 931 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| RESMED, INC. | Direttore/Membro del Consiglio | 15/08/2025 |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Vendite & Marketing | - |
| Società | Posizione | Fine |
|---|---|---|
| ABBVIE INC. | Corporate Officer/Principal | 01/09/2025 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
ResMed, Inc.
 ResMed, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and markets devices for evaluation and treatment of sleep disorders | Health Technology |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
